Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-25 @ 5:02 PM
Study NCT ID:
NCT05815303
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2023-04-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-01
First Submit QC Date:
None
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-13
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL